PRESS RELEASE published on 11/22/2024 at 15:55, 1 year 5 months ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution Signal Gold Inc. and ISS recommend voting FOR Arrangement Resolution and Private Placement Resolution. Shareholders encouraged to vote early to be held on December 6, 2024, at 11:00 a.m. Eastern. Contact Laurel Hill for voting assistance Signal Gold Inc. Arrangement Resolution Voting ISS Private Placement Resolution
PRESS RELEASE published on 11/22/2024 at 15:27, 1 year 5 months ago EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again Eckert & Ziegler SE raises its forecast for the current financial year with sales of EUR 290 million and EBIT of EUR 60 million. Investor contact: Karolin Riehle, EZAG Financial Year Forecast Eckert & Ziegler SE EUR 290 Million EBIT EUR 60 Million
PRESS RELEASE published on 11/22/2024 at 15:15, 1 year 5 months ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, presents positive preclinical data at SITC 39th Annual Meeting. Focus on advancing immune-oncology technologies to treat hard cancers Cancer Treatment Preclinical Data Immunotherapy SITC 39th Annual Meeting Dr. Reid Bissonnette
PRESS RELEASE published on 11/22/2024 at 14:46, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses 11.83% interest in International Paper Company. Form 8.3 filing made on 22-Nov-2024 Form 8.3 Vanguard Group Interest Disclosure Stock Holdings International Paper Company
PRESS RELEASE published on 11/22/2024 at 14:45, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc The Vanguard Group, Inc. discloses 2.20% ownership in Centamin plc as of 21 Nov 2024 Vanguard Group Ownership Disclosure Financial Disclosure Stock Market Centamin Plc
PRESS RELEASE published on 11/22/2024 at 14:45, 1 year 5 months ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs Jaguar Health, Inc. announces extension of FDA approval for Canalevia®-CA1 for chemotherapy-induced diarrhea in dogs, seeks partner for NP300 development at Pet Connect conference Jaguar Health Diarrhea Veterinary NP300 Canalevia®-CA1
PRESS RELEASE published on 11/22/2024 at 14:44, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc The Vanguard Group, Inc. discloses a 4.41% stake in AngloGold Ashanti plc. Also making disclosures related to Centamin plc. Details as per Form 8.3 Form 8.3 Disclosure Vanguard Group AngloGold Ashanti Centamin Plc
PRESS RELEASE published on 11/22/2024 at 14:43, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc The Vanguard Group, Inc. discloses a 3.78% stake in International Distribution Services plc. Public disclosure under Rule 8 of the Code Disclosure The Vanguard Group Stake International Distribution Services Plc Rule 8
PRESS RELEASE published on 11/22/2024 at 14:42, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. discloses their 3.96% ownership of Hargreaves Lansdown plc's 0.4p ordinary shares in a Form 8.3 filing as of 21 Nov 2024 Form 8.3 Vanguard Group Ownership Disclosure Financial Securities Hargreaves Lansdown Plc
PRESS RELEASE published on 11/22/2024 at 14:41, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.47% interest in Britvic plc through Form 8.3 per Takeover Code on 21 Nov 2024 The Vanguard Group, Inc. Form 8.3 Disclosure Britvic Plc Takeover Code
Published on 05/16/2026 at 01:15, 2 days 9 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 2 days 10 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/18/2026 at 10:35, 14 minutes ago Aliko Dangote: African Energy Person of the Year 2026
Published on 05/18/2026 at 10:35, 14 minutes ago Aliko Dangote : Personnalité africaine de l'année 2026 dans le domaine de l'énergie
Published on 05/18/2026 at 10:30, 19 minutes ago Haier Named the World's Only IoT Ecosystem Brand in Kantar BrandZ Top 100 for Eight Consecutive Years
Published on 05/18/2026 at 10:30, 19 minutes ago SafeFields and Veoneer Announce Strategic Agreement to Advance Automotive EMF Reduction Solutions
Published on 05/18/2026 at 10:00, 49 minutes ago ams OSRAM announces the offering of EUR 700 million senior notes and the entry into an amendment and restatement of its Revolving Credit Facility agreement
Published on 05/18/2026 at 08:30, 2 hours 19 minutes ago Thales appoints Jérémie Papin Senior Executive Vice-President, Finance and Information Systems
Published on 05/18/2026 at 08:30, 2 hours 19 minutes ago Thales nomme Jérémie Papin Directeur général, Finance et Systèmes d’Information
Published on 05/15/2026 at 15:08, 2 days 19 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 19 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 3 days ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.